Symbiotic Macrophage-Glioma Cell Interactions Reveal Synthetic Lethality in PTEN-Null Glioma

Cancer Cell - Tập 35 - Trang 868-884.e6 - 2019
Peiwen Chen1, Di Zhao1, Jun Li2, Xin Liang1, Jiexi Li1, Andrew Chang1, Verlene K. Henry3, Zhengdao Lan1, Denise J. Spring1, Ganesh Rao3, Y. Alan Wang1, Ronald A. DePinho1
1Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
2Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
3Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA

Tài liệu tham khảo

Baker, 2011, The role of lysyl oxidase in SRC-dependent proliferation and metastasis of colorectal cancer, J. Natl. Canc. Inst., 103, 407, 10.1093/jnci/djq569 Barker, 2012, The rationale for targeting the LOX family in cancer, Nat. Rev. Cancer, 12, 540, 10.1038/nrc3319 Bindea, 2013, Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer, Immunity, 39, 782, 10.1016/j.immuni.2013.10.003 Bonavia, 2012, EGFRvIII promotes glioma angiogenesis and growth through the NF-kappaB, interleukin-8 pathway, Oncogene, 31, 4054, 10.1038/onc.2011.563 Bowman, 2016, Macrophage ontogeny underlies differences in tumor-specific education in brain malignancies, Cell Rep., 17, 2445, 10.1016/j.celrep.2016.10.052 Bowman, 2017, GlioVis data portal for visualization and analysis of brain tumor expression datasets, Neuro Oncol., 19, 139, 10.1093/neuonc/now247 Brennan, 2013, The somatic genomic landscape of glioblastoma, Cell, 155, 462, 10.1016/j.cell.2013.09.034 Butowski, 2016, Orally administered colony stimulating factor 1 receptor inhibitor PLX3397 in recurrent glioblastoma: an Ivy Foundation Early Phase Clinical Trials Consortium phase II study, Neuro Oncol., 18, 557, 10.1093/neuonc/nov245 2008, Comprehensive genomic characterization defines human glioblastoma genes and core pathways, Nature, 455, 1061, 10.1038/nature07385 Cerami, 2012, The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data, Cancer Discov., 2, 401, 10.1158/2159-8290.CD-12-0095 Chen, 2015, New horizons in tumor microenvironment biology: challenges and opportunities, BMC Med., 13, 45, 10.1186/s12916-015-0278-7 Chen, 2017, Gpr132 sensing of lactate mediates tumor-macrophage interplay to promote breast cancer metastasis, Proc. Natl. Acad. Sci. U S A, 114, 580, 10.1073/pnas.1614035114 Chen, 2005, SPD–a web-based secreted protein database, Nucleic Acids Res., 33, D169, 10.1093/nar/gki093 Chen, 2017, Cellular and molecular identity of tumor-associated macrophages in glioblastoma, Cancer Res., 77, 2266, 10.1158/0008-5472.CAN-16-2310 Cox, 2015, The hypoxic cancer secretome induces pre-metastatic bone lesions through lysyl oxidase, Nature, 522, 106, 10.1038/nature14492 Dey, 2008, The protein phosphatase activity of PTEN regulates SRC family kinases and controls glioma migration, Cancer Res., 68, 1862, 10.1158/0008-5472.CAN-07-1182 Dunn, 2012, Emerging insights into the molecular and cellular basis of glioblastoma, Genes Dev., 26, 756, 10.1101/gad.187922.112 Ellert-Miklaszewska, 2016, Tumour-processed osteopontin and lactadherin drive the protumorigenic reprogramming of microglia and glioma progression, Oncogene, 35, 6366, 10.1038/onc.2016.55 Engler, 2012, Increased microglia/macrophage gene expression in a subset of adult and pediatric astrocytomas, PLoS One, 7, e43339, 10.1371/journal.pone.0043339 Erler, 2009, Hypoxia-induced lysyl oxidase is a critical mediator of bone marrow cell recruitment to form the premetastatic Niche, Cancer Cell, 15, 35, 10.1016/j.ccr.2008.11.012 Erler, 2006, Lysyl oxidase is essential for hypoxia-induced metastasis, Nature, 440, 1222, 10.1038/nature04695 Gabrusiewicz, 2016, Glioblastoma-infiltrated innate immune cells resemble M0 macrophage phenotype, JCI Insight, 1, 10.1172/jci.insight.85841 Gao, 2010, LKB1 inhibits lung cancer progression through lysyl oxidase and extracellular matrix remodeling, Proc. Natl. Acad. Sci. U S A, 107, 18892, 10.1073/pnas.1004952107 Guo, 2017, Single tumor-initiating cells evade immune clearance by recruiting type II macrophages, Genes Dev., 31, 247, 10.1101/gad.294348.116 Hambardzumyan, 2015, Glioblastoma: defining tumor niches, Trends Cancer, 1, 252, 10.1016/j.trecan.2015.10.009 Hambardzumyan, 2016, The role of microglia and macrophages in glioma maintenance and progression, Nat. Neurosci., 19, 20, 10.1038/nn.4185 Hill, 2018, On the design of CRISPR-based single-cell molecular screens, Nat. Methods, 15, 271, 10.1038/nmeth.4604 Hu, 2016, Epigenetic activation of WNT5A drives glioblastoma stem cell differentiation and invasive growth, Cell, 167, 1281, 10.1016/j.cell.2016.10.039 Hussain, 2006, The role of human glioma-infiltrating microglia/macrophages in mediating antitumor immune responses, Neuro Oncol., 8, 261, 10.1215/15228517-2006-008 Johnson, 2014, The two faces of Hippo: targeting the Hippo pathway for regenerative medicine and cancer treatment, Nat. Rev. Drug Discov., 13, 63, 10.1038/nrd4161 Kanamori, 2006, Intracranial microenvironment reveals independent opposing functions of host alphaVbeta3 expression on glioma growth and angiogenesis, J. Biol. Chem., 281, 37256, 10.1074/jbc.M605344200 Kapoor, 2014, Yap1 activation enables bypass of oncogenic Kras addiction in pancreatic cancer, Cell, 158, 185, 10.1016/j.cell.2014.06.003 Khosla, 2016, Concurrent therapy to enhance radiotherapeutic outcomes in glioblastoma, Ann. Transl. Med., 4, 54 Levental, 2009, Matrix crosslinking forces tumor progression by enhancing integrin signaling, Cell, 139, 891, 10.1016/j.cell.2009.10.027 Li, 2000, Hydrogen peroxide-mediated, lysyl oxidase-dependent chemotaxis of vascular smooth muscle cells, J. Cell Biochem., 78, 550, 10.1002/1097-4644(20000915)78:4<550::AID-JCB4>3.0.CO;2-8 Lim, 2018, Current state of immunotherapy for glioblastoma, Nat. Rev. Clin. Oncol., 15, 422, 10.1038/s41571-018-0003-5 Maher, 2001, Malignant glioma: genetics and biology of a grave matter, Genes Dev., 15, 1311, 10.1101/gad.891601 Marumoto, 2009, Development of a novel mouse glioma model using lentiviral vectors, Nat. Med., 15, 110, 10.1038/nm.1863 Matsuura, 2016, Lysyl oxidase is associated with increased thrombosis and platelet reactivity, Blood, 127, 1493, 10.1182/blood-2015-02-629667 Mayor, 2014, Clathrin-independent pathways of endocytosis, Cold Spring Harb. Perspect. Biol., 6, 10.1101/cshperspect.a016758 Morford, 1999, Apoptotic elimination of peripheral T lymphocytes in patients with primary intracranial tumors, J. Neurosurg., 91, 935, 10.3171/jns.1999.91.6.0935 Nabi, 2003, Caveolae/raft-dependent endocytosis, J. Cell Biol., 161, 673, 10.1083/jcb.200302028 Okigaki, 2003, Pyk2 regulates multiple signaling events crucial for macrophage morphology and migration, Proc. Natl. Acad. Sci. U S A, 100, 10740, 10.1073/pnas.1834348100 Palumbo, 2015, Genetic instability in the tumor microenvironment: a new look at an old neighbor, Mol. Cancer, 14, 145, 10.1186/s12943-015-0409-y Parsa, 2007, Loss of tumor suppressor PTEN function increases B7-H1 expression and immunoresistance in glioma, Nat. Med., 13, 84, 10.1038/nm1517 Patel, 2014, Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma, Science, 344, 1396, 10.1126/science.1254257 Pez, 2011, The HIF-1-inducible lysyl oxidase activates HIF-1 via the Akt pathway in a positive regulation loop and synergizes with HIF-1 in promoting tumor cell growth, Cancer Res., 71, 1647, 10.1158/0008-5472.CAN-10-1516 Pyonteck, 2013, CSF-1R inhibition alters macrophage polarization and blocks glioma progression, Nat. Med., 19, 1264, 10.1038/nm.3337 Quail, 2016, The tumor microenvironment underlies acquired resistance to CSF-1R inhibition in gliomas, Science, 352, 10.1126/science.aad3018 Quail, 2013, Microenvironmental regulation of tumor progression and metastasis, Nat. Med., 19, 1423, 10.1038/nm.3394 Rachman-Tzemah, 2017, Blocking surgically induced lysyl oxidase activity reduces the risk of lung metastases, Cell Rep., 19, 774, 10.1016/j.celrep.2017.04.005 Roberts, 2008, Antitumor activity and pharmacology of a selective focal adhesion kinase inhibitor, PF-562,271, Cancer Res., 68, 1935, 10.1158/0008-5472.CAN-07-5155 Roth, 2014, Challenges to targeting epidermal growth factor receptor in glioblastoma: escape mechanisms and combinatorial treatment strategies, Neuro Oncol., 16, viii14, 10.1093/neuonc/nou222 Saha, 2017, Macrophage polarization contributes to glioblastoma eradication by combination immunovirotherapy and immune checkpoint blockade, Cancer Cell, 32, 253, 10.1016/j.ccell.2017.07.006 Samaras, 2007, Application of the ELISPOT method for comparative analysis of interleukin (IL)-6 and IL-10 secretion in peripheral blood of patients with astroglial tumors, Mol. Cell. Biochem., 304, 343, 10.1007/s11010-007-9517-3 Shingu, 2017, Qki deficiency maintains sternness of glioma stem cells in suboptimal environment by downregulating endolysosomal degradation, Nat. Genet., 49, 75, 10.1038/ng.3711 Stein, 2015, YAP1 exerts its transcriptional control via TEAD-mediated activation of enhancers, PLoS Genet., 11, e1005465, 10.1371/journal.pgen.1005465 Subramanian, 2005, Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles, Proc. Natl. Acad. Sci. U S A, 102, 15545, 10.1073/pnas.0506580102 Szulzewsky, 2018, Loss of host-derived osteopontin creates a glioblastoma-promoting microenvironment, Neuro Oncol., 20, 355, 10.1093/neuonc/nox165 Tumaneng, 2012, YAP mediates crosstalk between the Hippo and PI(3)K-TOR pathways by suppressing PTEN via miR-29, Nat. Cell Biol., 14, 1322, 10.1038/ncb2615 Verhaak, 2010, Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1, Cancer Cell, 17, 98, 10.1016/j.ccr.2009.12.020 Wang, 2016, Targeting YAP-dependent MDSC infiltration impairs tumor progression, Cancer Discov., 6, 80, 10.1158/2159-8290.CD-15-0224 Wei, 2018, Osteopontin mediates glioblastoma-associated macrophage infiltration and is a therapeutic target, J. Clin. Invest., 129, 137, 10.1172/JCI121266 Wen, 2001, PTEN controls tumor-induced angiogenesis, Proc. Natl. Acad. Sci. U S A, 98, 4622, 10.1073/pnas.081063798 Yamamoto, 2008, TRPM2-mediated Ca2+influx induces chemokine production in monocytes that aggravates inflammatory neutrophil infiltration, Nat. Med., 14, 738, 10.1038/nm1758 Yoshihara, 2013, Inferring tumour purity and stromal and immune cell admixture from expression data, Nat. Commun., 4, 2612, 10.1038/ncomms3612 Zerrouqi, 2012, P14ARF inhibits human glioblastoma-induced angiogenesis by upregulating the expression of TIMP3, J. Clin. Invest., 122, 1283, 10.1172/JCI38596 Zhao, 2017, Synthetic essentiality of chromatin remodelling factor CHD1 in PTEN-deficient cancer, Nature, 542, 484, 10.1038/nature21357 Zheng, 2008, Pten and p53 converge on c-Myc to control differentiation, self-renewal, and transformation of normal and neoplastic stem cells in glioblastoma, Cold Spring Harb. Symp. Quant. Biol., 73, 427, 10.1101/sqb.2008.73.047 Zhu, 2017, The contribution of tumor-associated macrophages in glioma neo-angiogenesis and implications for anti-angiogenic strategies, Neuro Oncol., 19, 1435, 10.1093/neuonc/nox081 Zhu, 2002, The molecular and genetic basis of neurological tumours, Nat. Rev. Cancer, 2, 616, 10.1038/nrc866